MuyldermansGroup

Interactions between Metal-binding Domains Modulate Intracellular Targeting of Cu(I)-ATPase ATP7B, as Revealed by Nanobody Binding.

Huang, Y., S. Nokhrin, G. Hassanzadeh-Ghassabeh, C. H. Yu, H. Yang, A. N. Barry, M. Tonelli, J. L. Markley, S. Muyldermans, O. Y. Dmitriev, et al., "Interactions between Metal-binding Domains Modulate Intracellular Targeting of Cu(I)-ATPase ATP7B, as Revealed by Nanobody Binding.", J Biol Chem, vol. 289, issue 47, pp. 32682-93, 2014 Nov 21.

TRIM28 and β-Actin Identified via Nanobody-Based Reverse Proteomics Approach as Possible Human Glioblastoma Biomarkers.

Jovčevska, I., N. Zupanec, N. Kočevar, D. Cesselli, N. Podergajs, C. Limbaeck Stokin, M. P. Myers, S. Muyldermans, G. Hassanzade Ghassabeh, H. Motaln, et al., "TRIM28 and β-Actin Identified via Nanobody-Based Reverse Proteomics Approach as Possible Human Glioblastoma Biomarkers.", PLoS One, vol. 9, issue 11, pp. e113688, 2014.

Monitoring liver macrophages using nanobodies targeting Vsig4: Concanavalin A induced acute hepatitis as paradigm.

Zheng, F., N. Devoogdt, A. Sparkes, Y. Morias, C. Abels, B. Stijlemans, T. Lahoutte, S. Muyldermans, P. De Baetselier, S. Schoonooghe, et al., "Monitoring liver macrophages using nanobodies targeting Vsig4: Concanavalin A induced acute hepatitis as paradigm.", Immunobiology, vol. 220, issue 2, pp. 200-9, 2015 Feb.

Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target.

De Vos, J., N. Devoogdt, T. Lahoutte, and S. Muyldermans, "Camelid single-domain antibody-fragment engineering for (pre)clinical in vivo molecular imaging applications: adjusting the bullet to its target.", Expert Opin Biol Ther, vol. 13, issue 8, pp. 1149-60, 2013 Aug.

Pages

Subscribe to RSS - MuyldermansGroup